Key regions: United Kingdom, Germany, France, South Korea, Italy
Jordan, like many other countries, has been actively rolling out COVID-19 vaccines to its population. The COVID-19 Vaccines market in Jordan has seen some interesting trends and developments in recent times.
Customer preferences: The majority of Jordan's population has shown a willingness to receive the COVID-19 vaccine. This is largely due to the high level of trust that the Jordanian people have in their healthcare system. Additionally, the government has been actively promoting the vaccine and has made it easily accessible to the public.
Trends in the market: One interesting trend in the COVID-19 Vaccines market in Jordan is the increasing demand for the Pfizer-BioNTech vaccine. This vaccine has been shown to be highly effective against the COVID-19 virus and has been approved for emergency use by the World Health Organization. Another trend is the government's decision to prioritize the vaccination of certain groups, such as healthcare workers and the elderly. This has helped to ensure that those who are most vulnerable to the virus are protected.
Local special circumstances: Jordan is a relatively small country with a population of around 10 million people. This has made it easier for the government to roll out the vaccine quickly and efficiently. Additionally, the country has a well-developed healthcare system that has been able to handle the logistics of distributing the vaccine.
Underlying macroeconomic factors: The COVID-19 Vaccines market in Jordan is largely influenced by global factors such as vaccine supply and demand. The government has had to work closely with vaccine manufacturers to ensure that there is enough supply to meet the demand. Additionally, the country's economy has been impacted by the pandemic, with many businesses and industries suffering. The rollout of the vaccine is seen as a key factor in helping to revive the economy and get things back to normal.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
